Oct 15, 2018 - Epidiolex will soon be hitting the shelves.Its success or failure in the market will have huge implications across the pure botanical medical cannabis space.GW Pharmaceuticals has the challenge of con
Oct 12, 2018 - Dorsey Wright & Associates Buys GW Pharmaceuticals PLC, Icon PLC, AerCap Holdings NV, Sells Empresa Distribuidora y Comercializadora Norte SA, Sociedad Quimica Y Minera De Chile SA, SodaStream International, Stocks: BIO,ALGN,NRG,PBF,MA,URBN,GWPH,ICLR,AER,SHPG,TOT,SN, release date:Oct 12, 2018
Oct 11, 2018 - Conventional wisdom suggests that shares of DavidsTea traded up 63% (On Oct. 2nd) based on speculation, however, there is more to the story.On late September 27th, the DEA moved CBD from its list of S
Oct 02, 2018 - Canada is set to flip the switch for legal sale of recreational marijuana in just a few weeks.Marijuana stocks are taking center stage ahead of Canada's legalization so investors should be aware of th
Sep 27, 2018 - Pot stocks ripped higher Thursday after the DEA classified a cannabidiol-based drug made by GW Pharmaceuticals in its least restrictive category.
Sep 27, 2018 - This paves the way for GW Pharmaceuticals to start selling the first FDA-approved drug that's derived from cannabis, but the DEA stopped short of reclassifying all cannabidiol products.
Sep 19, 2018 - Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.
Sep 19, 2018 - Tilray CEO Brendan Kennedy told CNBC that pharmaceutical companies must start thinking about partnering with cannabis producers as a "hedge" against the space.
Sep 13, 2018 - Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.
Sep 13, 2018 - Marijuana has the potential to take share away from domestic brewers.If you can’t beat them, join them.And if you’re going to form a strategic partnership, you might as well do it with a market leader